Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database (Q5977801)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database |
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database |
scientific article |
Statements
72
0 references
6
0 references
905-908
0 references
9 November 2011
0 references
